Leading providers of investment research, business and IP research and company valuation services
According to Technopark Advisors, healthcare, which is a US$ 35 billion industry in India, is expected to reach over US$ 75 billion by 2012 and US$ 150 billion by 2017. The healthcare industry is interestingly poised as it strives to emerge as a global hub due to the distinct advantages it enjoys in clinical excellence [...]
According to IMS Health, Germany accounted for approximately $35 bn in drug sales (up 4% y-o-y), followed by France’s $31 bn (same y-o-y), Italy’s $17.2 bn (up 1%), UK’s $16 bn (down 2%) and Spain’s $15 bn (up 4%).
Generics sales in France, Italy and Spain increased 17%, 13% and 11% respectively, according to IMS Health.
Canadian Generic Pharmaceutical Association (CGPA) cites IMS while stating that the average cost of brand-name prescriptions in 2007 was CAD 64.19, and that of generic prescriptions was CAD 26.07. Also, average price of the former increased 50%, vis-à-vis the latter’s 34% growth over the last 10 years.
Global pharmaceuticals market grew from $560bn in 2004 to $712bn in 2007. The strongest growth in 2007 was exhibited by Eastern European, Latin American and Asian markets. In 2006 the industry registered revenues of $649bn. US was the largest revenue contributor with a share of 43%, followed by Europe (31%) and Japan (9%). Source: German [...]
